+ All Categories
Home > Documents > C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION...

C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION...

Date post: 11-May-2018
Category:
Upload: vuongliem
View: 215 times
Download: 2 times
Share this document with a friend
12
TDMS No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) TEF TRANSGENICS (TCDD) CAS Number: 1746-01-6 Date Report Reqsted: 06/14/2006 Time Report Reqsted: 13:12:56 First Dose M/F: NA / 04/21/03 Lab: BAT C Number: C20201A Lock Date: 07/24/2004 Cage Range: ALL Date Range: ALL Reasons For Removal: ALL Removal Date Range: ALL Treatment Groups: Include 001 0 NG/KG Include 002 121 NG/KG Include 003 760 NG/KG Note: Animals arranged according to days on test.
Transcript
Page 1: C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI

TDMS No. 20201 - 01

Test Type: 26-WEEK

Route: SKIN APPLICATION

Species/Strain: MICE/TG.AC HEMI

P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) TEF TRANSGENICS (TCDD)

CAS Number: 1746-01-6

Date Report Reqsted: 06/14/2006

Time Report Reqsted: 13:12:56

First Dose M/F: NA / 04/21/03

Lab: BAT

C Number: C20201A

Lock Date: 07/24/2004

Cage Range: ALL

Date Range: ALL

Reasons For Removal: ALL

Removal Date Range: ALL

Treatment Groups: Include 001 0 NG/KG Include 002 121 NG/KG Include 003 760 NG/KG

Note: Animals arranged according to days on test.

Page 2: C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI

TDMS No. 20201 - 01 P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) Date Report Reqsted: 06/14/2006

Test Type: 26-WEEK TEF TRANSGENICS (TCDD) Time Report Reqsted: 13:12:56

Route: SKIN APPLICATION CAS Number: 1746-01-6 First Dose M/F: NA / 04/21/03

Species/Strain: MICE/TG.AC HEMI Lab: BAT

0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 7 8 6 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8

4 1 5 3 3 3 4 4 4 5 5 5 5 6 6 6 6 6 7 7 .................................................................................................................................................................

TGAC (FVB/N) HEMIZYGOUS MICE FEMALE

ANIMAL ID 0 NG/KG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 2 0 0 0 1 0 0 0 1 1 0 1 2 4 8 2 0 5 6 9 0 3 4 7 1 5 6 9 7 8 1 3 * TOTALS

ALIMENTARY SYSTEM .........................................................................................................................................................................................................

Liver + + + + + + + + + + + + + + + + + + + + 20 .........................................................................................................................................................................................................

Mesentery + 1 .........................................................................................................................................................................................................

Salivary Glands + 1

Squamous Cell Carcinoma X 1 .........................................................................................................................................................................................................

Stomach, Forestomach + + + + + + 6

Squamous Cell Papilloma X X X X 4

Squamous Cell Papilloma, Multiple X 1 .........................................................................................................................................................................................................

Stomach, Glandular + 1 .........................................................................................................................................................................................................

Tooth + + + + + + 6

Odontogenic Tumor X X X X X 5

Odontogenic Tumor, Multiple X 1

CARDIOVASCULAR SYSTEM NONE

ENDOCRINE SYSTEM NONE

* .. Total animals with tissue examined microscopically; Total animals with tumor M .. Missing tissue + .. Tissue examined microscopically A .. Autolysis precludes evaluation x .. Lesion present BLANK .. Not examined microscopically I .. Insufficient tissue

Page 2

Page 3: C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI

TDMS No. 20201 - 01 P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) Date Report Reqsted: 06/14/2006

Test Type: 26-WEEK TEF TRANSGENICS (TCDD) Time Report Reqsted: 13:12:56

Route: SKIN APPLICATION CAS Number: 1746-01-6 First Dose M/F: NA / 04/21/03

Species/Strain: MICE/TG.AC HEMI Lab: BAT

0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 7 8 6 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8

4 1 5 3 3 3 4 4 4 5 5 5 5 6 6 6 6 6 7 7 .................................................................................................................................................................

TGAC (FVB/N) HEMIZYGOUS MICE FEMALE

ANIMAL ID 0 NG/KG

GENERAL BODY SYSTEM NONE

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 2 0 0 0 1 0 0 0 1 1 0 1 2 4 8 2 0 5 6 9 0 3 4 7 1 5 6 9 7 8 1 3 * TOTALS

GENITAL SYSTEM .........................................................................................................................................................................................................

Ovary + 1

HEMATOPOIETIC SYSTEM .........................................................................................................................................................................................................

Lymph Node, Mesenteric + 1 .........................................................................................................................................................................................................

Spleen + + + + + + + + + + + + + + + + + + + + 20 .........................................................................................................................................................................................................

Thymus + + + + + + + + + + + + + + + + + + + + 20

INTEGUMENTARY SYSTEM .........................................................................................................................................................................................................

Skin + + + + 4 .........................................................................................................................................................................................................

Skin, Control Dermis + + + + + + + + + + + + + + + + + + + + 20 .........................................................................................................................................................................................................

Skin, Control Epidermis + + + + + + + + + + + + + + + + + + + + 20 .........................................................................................................................................................................................................

Skin, Site Of Application + + + + + + + + + + + + + + + + + + + + 20

* .. Total animals with tissue examined microscopically; Total animals with tumor M .. Missing tissue + .. Tissue examined microscopically A .. Autolysis precludes evaluation x .. Lesion present BLANK .. Not examined microscopically I .. Insufficient tissue

Page 3

Page 4: C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI

TDMS No. 20201 - 01 P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) Date Report Reqsted: 06/14/2006

Test Type: 26-WEEK TEF TRANSGENICS (TCDD) Time Report Reqsted: 13:12:56

Route: SKIN APPLICATION CAS Number: 1746-01-6 First Dose M/F: NA / 04/21/03

Species/Strain: MICE/TG.AC HEMI Lab: BAT

0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 7 8 6 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8

4 1 5 3 3 3 4 4 4 5 5 5 5 6 6 6 6 6 7 7 .................................................................................................................................................................

TGAC (FVB/N) HEMIZYGOUS MICE FEMALE

ANIMAL ID 0 NG/KG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 2 0 0 0 1 0 0 0 1 1 0 1 2 4 8 2 0 5 6 9 0 3 4 7 1 5 6 9 7 8 1 3 * TOTALS

Squamous Cell Papilloma

Skin, Soa No Mass

X 1 .........................................................................................................................................................................................................

+ + + + + + + + + + + + + + + + + + + + 20

MUSCULOSKELETAL SYSTEM NONE

NERVOUS SYSTEM NONE

RESPIRATORY SYSTEM

Lung

Alveolar/Bronchiolar Adenoma

......................................................................................................................................................................................................... + + + + + + + + + + + + + + + + + + + + 20

X 1

SPECIAL SENSES SYSTEM NONE

URINARY SYSTEM NONE

SYSTEMIC LESIONS .........................................................................................................................................................................................................

Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

* .. Total animals with tissue examined microscopically; Total animals with tumor M .. Missing tissue + .. Tissue examined microscopically A .. Autolysis precludes evaluation x .. Lesion present BLANK .. Not examined microscopically I .. Insufficient tissue

Page 4

Page 5: C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI

TDMS No. 20201 - 01 P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) Date Report Reqsted: 06/14/2006

Test Type: 26-WEEK TEF TRANSGENICS (TCDD) Time Report Reqsted: 13:12:56

Route: SKIN APPLICATION CAS Number: 1746-01-6 First Dose M/F: NA / 04/21/03

Species/Strain: MICE/TG.AC HEMI Lab: BAT

0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 7 8 6 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8

4 1 5 3 3 3 4 4 4 5 5 5 5 6 6 6 6 6 7 7 .................................................................................................................................................................

TGAC (FVB/N) HEMIZYGOUS MICE FEMALE

ANIMAL ID 0 NG/KG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 2 0 0 0 1 0 0 0 1 1 0 1 2 4 8 2 0 5 6 9 0 3 4 7 1 5 6 9 7 8 1 3 * TOTALS

Leukemia Erythrocytic X 1

* .. Total animals with tissue examined microscopically; Total animals with tumor M .. Missing tissue + .. Tissue examined microscopically A .. Autolysis precludes evaluation x .. Lesion present BLANK .. Not examined microscopically I .. Insufficient tissue

Page 5

Page 6: C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI

TDMS No. 20201 - 01 P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) Date Report Reqsted: 06/14/2006

Test Type: 26-WEEK TEF TRANSGENICS (TCDD) Time Report Reqsted: 13:12:56

Route: SKIN APPLICATION CAS Number: 1746-01-6 First Dose M/F: NA / 04/21/03

Species/Strain: MICE/TG.AC HEMI Lab: BAT

0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 5 0 1 2 2 5 6 7 8 8 8 8 8 8 8 8 8 8 8 8

7 2 0 2 3 0 3 2 3 3 3 3 3 3 3 3 4 4 6 7 .................................................................................................................................................................

TGAC (FVB/N) HEMIZYGOUS MICE FEMALE

ANIMAL ID 121 NG/KG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 0 1 0 0 0 0 0 1 1 1 1 1 1 2 0 9 2 6 4 6 8 8 9 1 2 3 5 0 1 5 7 3 4 0 7 * TOTALS

ALIMENTARY SYSTEM .........................................................................................................................................................................................................

Liver + + + + + + + + + + + + + + + + + + + + 20 .........................................................................................................................................................................................................

Stomach, Forestomach + + + + 4

Squamous Cell Papilloma X X X X 4 .........................................................................................................................................................................................................

Tooth + + + + + + 6

Odontogenic Tumor X X X X 4

Odontogenic Tumor, Multiple X X 2

CARDIOVASCULAR SYSTEM

Heart .........................................................................................................................................................................................................

+ 1

ENDOCRINE SYSTEM NONE

GENERAL BODY SYSTEM NONE

GENITAL SYSTEM NONE

* .. Total animals with tissue examined microscopically; Total animals with tumor M .. Missing tissue + .. Tissue examined microscopically A .. Autolysis precludes evaluation x .. Lesion present BLANK .. Not examined microscopically I .. Insufficient tissue

Page 6

Page 7: C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI

TDMS No. 20201 - 01 P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) Date Report Reqsted: 06/14/2006

Test Type: 26-WEEK TEF TRANSGENICS (TCDD) Time Report Reqsted: 13:12:56

Route: SKIN APPLICATION CAS Number: 1746-01-6 First Dose M/F: NA / 04/21/03

Species/Strain: MICE/TG.AC HEMI Lab: BAT

0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 5 0 1 2 2 5 6 7 8 8 8 8 8 8 8 8 8 8 8 8

7 2 0 2 3 0 3 2 3 3 3 3 3 3 3 3 4 4 6 7 .................................................................................................................................................................

TGAC (FVB/N) HEMIZYGOUS MICE FEMALE

ANIMAL ID 121 NG/KG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 0 1 0 0 0 0 0 1 1 1 1 1 1 2 0 9 2 6 4 6 8 8 9 1 2 3 5 0 1 5 7 3 4 0 7 * TOTALS

HEMATOPOIETIC SYSTEM .........................................................................................................................................................................................................

Lymph Node, Mandibular + 1 .........................................................................................................................................................................................................

Spleen + + + + + + + + + + + + + + + + + + + + 20 .........................................................................................................................................................................................................

Thymus + + + + + + M + + + + + + + + + + + + + 19

INTEGUMENTARY SYSTEM .........................................................................................................................................................................................................

Skin + + 2

Squamous Cell Papilloma X X 2 .........................................................................................................................................................................................................

Skin, Control Dermis + + + + + + + + + + + + + + + + + + + + 20 .........................................................................................................................................................................................................

Skin, Control Epidermis + + + + + + + + + + + + + + + + + + + + 20 .........................................................................................................................................................................................................

Skin, Site Of Application + + + + + + + + + + + + + + + + + + + + 20

Squamous Cell Papilloma X X 2

Squamous Cell Papilloma, Multiple X X X X X X X X X X X X X X 14 .........................................................................................................................................................................................................

Skin, Soa No Mass + + + + + + + + + + + + + + + + + + + + 20

MUSCULOSKELETAL SYSTEM

* .. Total animals with tissue examined microscopically; Total animals with tumor M .. Missing tissue + .. Tissue examined microscopically A .. Autolysis precludes evaluation x .. Lesion present BLANK .. Not examined microscopically I .. Insufficient tissue

Page 7

Page 8: C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI

TDMS No. 20201 - 01 P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) Date Report Reqsted: 06/14/2006

Test Type: 26-WEEK TEF TRANSGENICS (TCDD) Time Report Reqsted: 13:12:56

Route: SKIN APPLICATION CAS Number: 1746-01-6 First Dose M/F: NA / 04/21/03

Species/Strain: MICE/TG.AC HEMI Lab: BAT

0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 5 0 1 2 2 5 6 7 8 8 8 8 8 8 8 8 8 8 8 8

7 2 0 2 3 0 3 2 3 3 3 3 3 3 3 3 4 4 6 7 .................................................................................................................................................................

TGAC (FVB/N) HEMIZYGOUS MICE FEMALE

ANIMAL ID 121 NG/KG

NONE

NERVOUS SYSTEM NONE

RESPIRATORY SYSTEM

Lung

Alveolar/Bronchiolar Adenoma

......................................................................................................................................................................................................... + + + + + + + + + + + + + + + + + + + + 20

X 1

SPECIAL SENSES SYSTEM NONE

URINARY SYSTEM NONE

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 0 1 0 0 0 0 0 1 1 1 1 1 1 2 0 9 2 6 4 6 8 8 9 1 2 3 5 0 1 5 7 3 4 0 7 * TOTALS

SYSTEMIC LESIONS .........................................................................................................................................................................................................

Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

* .. Total animals with tissue examined microscopically; Total animals with tumor M .. Missing tissue + .. Tissue examined microscopically A .. Autolysis precludes evaluation x .. Lesion present BLANK .. Not examined microscopically I .. Insufficient tissue

Page 8

Page 9: C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI

TDMS No. 20201 - 01 P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) Date Report Reqsted: 06/14/2006

Test Type: 26-WEEK TEF TRANSGENICS (TCDD) Time Report Reqsted: 13:12:56

Route: SKIN APPLICATION CAS Number: 1746-01-6 First Dose M/F: NA / 04/21/03

Species/Strain: MICE/TG.AC HEMI Lab: BAT

0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 9 2 2 4 5 5 5 5 8 8 8 8 8 8 8 8 8 8 8

4 7 2 9 3 1 5 5 6 3 3 4 4 4 4 5 5 5 5 7 .................................................................................................................................................................

TGAC (FVB/N) HEMIZYGOUS MICE FEMALE

ANIMAL ID 760 NG/KG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4 3 2 2 2 2 3 3 3 2 3 2 3 3 3 2 2 2 3 3 0 4 5 2 8 6 1 6 9 3 3 7 0 5 7 1 4 9 8 2 * TOTALS

ALIMENTARY SYSTEM .........................................................................................................................................................................................................

Liver + + + + + + + + + + + + + + + + + + + + 20 .........................................................................................................................................................................................................

Mesentery + 1 .........................................................................................................................................................................................................

Stomach, Forestomach + + + + + 5

Squamous Cell Papilloma X X 2

Squamous Cell Papilloma, Multiple X X 2 .........................................................................................................................................................................................................

Stomach, Glandular + 1 .........................................................................................................................................................................................................

Tooth + + 2

Odontogenic Tumor X 1

Odontogenic Tumor, Multiple X 1

CARDIOVASCULAR SYSTEM .........................................................................................................................................................................................................

Heart + 1

ENDOCRINE SYSTEM .........................................................................................................................................................................................................

Adrenal Cortex + 1

* .. Total animals with tissue examined microscopically; Total animals with tumor M .. Missing tissue + .. Tissue examined microscopically A .. Autolysis precludes evaluation x .. Lesion present BLANK .. Not examined microscopically I .. Insufficient tissue

Page 9

Page 10: C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI

TDMS No. 20201 - 01 P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) Date Report Reqsted: 06/14/2006

Test Type: 26-WEEK TEF TRANSGENICS (TCDD) Time Report Reqsted: 13:12:56

Route: SKIN APPLICATION CAS Number: 1746-01-6 First Dose M/F: NA / 04/21/03

Species/Strain: MICE/TG.AC HEMI Lab: BAT

0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 9 2 2 4 5 5 5 5 8 8 8 8 8 8 8 8 8 8 8

4 7 2 9 3 1 5 5 6 3 3 4 4 4 4 5 5 5 5 7 .................................................................................................................................................................

TGAC (FVB/N) HEMIZYGOUS MICE FEMALE

ANIMAL ID 760 NG/KG

GENERAL BODY SYSTEM NONE

GENITAL SYSTEM NONE

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4 3 2 2 2 2 3 3 3 2 3 2 3 3 3 2 2 2 3 3 0 4 5 2 8 6 1 6 9 3 3 7 0 5 7 1 4 9 8 2 * TOTALS

HEMATOPOIETIC SYSTEM .........................................................................................................................................................................................................

Lymph Node + 1

Squamous Cell Carcinoma, Metastatic, X 1 Skin

......................................................................................................................................................................................................... Lymph Node, Mandibular + + 2

......................................................................................................................................................................................................... Spleen + + + + + + + + + + + + + + + + + + + + 20

......................................................................................................................................................................................................... Thymus + + + + + + + + + + + + M + + + + + + + 19

INTEGUMENTARY SYSTEM .........................................................................................................................................................................................................

Skin + + + + + + 6

Squamous Cell Carcinoma X 1

Squamous Cell Papilloma X X X 3

Squamous Cell Papilloma, Multiple X X 2

* .. Total animals with tissue examined microscopically; Total animals with tumor M .. Missing tissue + .. Tissue examined microscopically A .. Autolysis precludes evaluation x .. Lesion present BLANK .. Not examined microscopically I .. Insufficient tissue

Page 10

Page 11: C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI

TDMS No. 20201 - 01 P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) Date Report Reqsted: 06/14/2006

Test Type: 26-WEEK TEF TRANSGENICS (TCDD) Time Report Reqsted: 13:12:56

Route: SKIN APPLICATION CAS Number: 1746-01-6 First Dose M/F: NA / 04/21/03

Species/Strain: MICE/TG.AC HEMI Lab: BAT

0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 9 2 2 4 5 5 5 5 8 8 8 8 8 8 8 8 8 8 8

4 7 2 9 3 1 5 5 6 3 3 4 4 4 4 5 5 5 5 7 .................................................................................................................................................................

TGAC (FVB/N) HEMIZYGOUS MICE FEMALE

ANIMAL ID 760 NG/KG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4 3 2 2 2 2 3 3 3 2 3 2 3 3 3 2 2 2 3 3 0 4 5 2 8 6 1 6 9 3 3 7 0 5 7 1 4 9 8 2 * TOTALS

......................................................................................................................................................................................................... Skin, Control Dermis + + + + + + + + + + + + + + + + + + + + 20

......................................................................................................................................................................................................... Skin, Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

......................................................................................................................................................................................................... Skin, Site Of Application + + + + + + + + + + + + + + + + + + + + 20

Keratoacanthoma X 1

Spindle Cell Carcinoma X X X 3

Spindle Cell Carcinoma, Multiple X 1

Squamous Cell Carcinoma X X X X X X X X 8

Squamous Cell Carcinoma, Multiple X 1

Squamous Cell Papilloma, Multiple X X X X X X X X X X X X X X X X X X X 19 .........................................................................................................................................................................................................

Skin, Soa No Mass + + + + + + + + + + + + + + + + + 17

MUSCULOSKELETAL SYSTEM NONE

NERVOUS SYSTEM NONE

RESPIRATORY SYSTEM

Lung .........................................................................................................................................................................................................

+ + + + + + + + + + + + + + + + + + + + 20

* .. Total animals with tissue examined microscopically; Total animals with tumor M .. Missing tissue + .. Tissue examined microscopically A .. Autolysis precludes evaluation x .. Lesion present BLANK .. Not examined microscopically I .. Insufficient tissue

Page 11

Page 12: C Number: ALL - ntp.niehs.nih.gov No. 20201 - 01 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI

TDMS No. 20201 - 01 P17: NEOPLASMS BY INDIVIDUAL ANIMAL (SYSTEMIC LESIONS ABRIDGED) Date Report Reqsted: 06/14/2006

Test Type: 26-WEEK TEF TRANSGENICS (TCDD) Time Report Reqsted: 13:12:56

Route: SKIN APPLICATION CAS Number: 1746-01-6 First Dose M/F: NA / 04/21/03

Species/Strain: MICE/TG.AC HEMI Lab: BAT

0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 9 2 2 4 5 5 5 5 8 8 8 8 8 8 8 8 8 8 8

4 7 2 9 3 1 5 5 6 3 3 4 4 4 4 5 5 5 5 7 .................................................................................................................................................................

TGAC (FVB/N) HEMIZYGOUS MICE FEMALE

ANIMAL ID 760 NG/KG

SPECIAL SENSES SYSTEM NONE

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4 3 2 2 2 2 3 3 3 2 3 2 3 3 3 2 2 2 3 3 0 4 5 2 8 6 1 6 9 3 3 7 0 5 7 1 4 9 8 2 * TOTALS

URINARY SYSTEM .........................................................................................................................................................................................................

Kidney + + 2

SYSTEMIC LESIONS .........................................................................................................................................................................................................

Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Myelodysplasia X X 2

*** END OF REPORT ***

* .. Total animals with tissue examined microscopically; Total animals with tumor M .. Missing tissue + .. Tissue examined microscopically A .. Autolysis precludes evaluation x .. Lesion present BLANK .. Not examined microscopically I .. Insufficient tissue

Page 12


Recommended